Human parechovirus 3 (HPeV3) infection is associated with sepsis in neonates characterized by 21 significant immune activation and subsequent tissue damage. Strategies to limit infection have been 22 unsuccessful due to inadequate molecular diagnostic tools for early detection and lack of a vaccine 23 or specific antiviral therapy. Towards the latter, we present a 2.8 Å-resolution structure of HPeV3 in 24 complex with fragments from a neutralizing human monoclonal antibody AT12-015 using cryo-EM 25 and image reconstruction. Modeling revealed that the epitope extends across neighboring 26 asymmetric units with contributions from capsid proteins VP0, VP1, and VP3. Antibody decoration 27 was found to block binding of HPeV3 to cultured cells. Additionally at high-resolution, it was 28 possible to model a stretch of RNA inside the virion and from this identify the key features that 29 drive and stabilize protein-RNA association during assembly. 30
dysregulated host response often involving the central nervous system (3-9). In cases of acute 48 meningitis or encephalitis where patients may develop abnormal white matter lesions, neurological 49 sequelae and even death may occur (10) (11) (12) (13) (14) (15) . To date, no effective treatments for HPeV3 infection 50 are available, highlighting the urgent need for a greater understanding of the structural and 51 molecular basis for HPeV3 neutralization, especially as epidemics are likely to continue (2, (16) (17) (18) . 52
The HPeV3 virion is composed of 60 copies of the three structural proteins (VP0, VP1, and VP3) 53 that fit together to form a 28-nm-diameter icosahedral shell around the ~7.3 kb single-stranded 54 RNA viral genome (19) . The genome encodes a single polyprotein that during infection is 55 subsequently cleaved into all the essential capsid components and replication proteins (2A, 2B, 2C, 56 3A, 3B, 3C and 3D) (20). In HPeV1, recent work has shown that newly synthesized viral RNA 57 contains ~60 spatially defined, conserved sequence/structure GXUXUXXU motifs that bind capsid 58 proteins, driving genome encapsidation and efficient capsid self-assembly (21, 22) . Assembled 59 capsids lack cleavage of VP0 into VP2 and VP4 products, resulting in a shell made of three proteins 60 rather than the four found in most other picornaviruses. Around the pentamers there is a depression 61 referred to as the canyon. The tips of the three-fold symmetric propeller-like protrusions are 62 adjacent to this canyon. 63
The VP1 C terminus of several human parechoviruses (e.g., HPeV -1, -2, -4, and -5) contains an 64 arginine-glycine-aspartic acid (RGD) motif that can attach to αVβ1, αVβ3, and αVβ6 integrin 65 receptors (23, 24). HPeV3 lacks the RGD motif and thus likely uses a different, as yet unknown, 66 receptor for cell entry (25) . Reliance on a different receptor may alter tissue tropism and could 67 explain why HPeV3 infections have different clinical and epidemiological features compared to 68 other HPeV genotypes. 69
Human monoclonal antibodies (mAbs) can be exploited to gain valuable insights into the structural 70 basis for neutralizing activity, which in turn can be used for developing effective treatments. High-71 4 resolution mapping of mAb sites at the HPeV3 capsid surface allows for identification of epitopes 72 recognized by the humoral immune system and may begin to provide mechanistic clues into 73 immune surveillance, evasion, or escape. Here, using high-resolution cryo-EM we define such an 74 epitope, that when targeted by a human monoclonal antibody, blocks attachment of virions to host 75 cells; hence also describing a potential site for receptor binding. 76
Results 77
Cryo-EM structure of the HPeV3-Fab AT12-015 complex 78
Cryo-grids containing vitrified Fab-labeled virus were imaged and after data processing in 79 RELION , a total of 74,927 particle projections were selected, which yielded a 3D reconstruction 80 extending to 2.8 Å resolution according to the gold-standard Fourier shell correlation 0.143 81 criterion (Table 1 and Figure 1A ) (26). Fab decoration on the capsid surface helped to assign 82 particle orientations during data processing. The capsid was resolved to 2.3 Å, whereas small 83 stretches of capsid associated RNA and peripheral regions of Fab were defined at a resolution lower 84 than 3.5 Å ( Figure 1B ). In the structure, Fab molecules bind to symmetry-related sites at the tips of 85 the propellers on the surface of the virion (Figure 2A -C). For fitting, large regions of the map 86 showed clear delineation of secondary structural elements, including amino acid and nucleic acid 87 densities ( Figure 2D -G). In this manner, we could accurately map the antibody footprint on the 88 capsid surface, as well as visualize an RNA base-stacking motif that stably anchors the genome to 89 the capsid via interaction with a tryptophan residue (Trp 24) in the HPeV3 VP3 coat protein ( Figure  90 2F and G). 91
Characterization of the Fab AT12-015 Epitope 92
In the reconstruction, the signal related to the Fab heavy and light chains is roughly as strong as that 93 of the viral capsid, indicating 100% occupancy of the 60 available binding sites on the virion 94 ( Figure 1B ). The quality of the map was such that we could fit atomic coordinates for the Fab, as 95 well as for the three viral coat proteins, and this was followed by MDFF all-atom refinement. 96
Results from flexible fitting revealed that the Fab targets an extended, solvent-accessible VP0-VP1-97 5 VP1´-VP3´ (´ denotes a neighboring asymmetric unit) conformational epitope. There is no evidence 98 of induced structural changes in any of the capsid proteins upon Fab binding. Using a 3.6 Å 99 distance cutoff we identified 28 capsid residues forming the epitope and 29 Fab residues that form 100 the paratope ( Figure 3A) . Residues from the capsid that are involved in forming the immune 101 complex are conserved among HPeV3 strains, but not for HPeV1 or other parechovirus types. Six 102 hydrogen bonds at the interface were identified, three from the heavy chain: Arg 58 to VP1 residue 103 Asp 87, Tyr 59 to VP1 residue Asn 138, and Arg 99 to VP3 residue Leu 252, and three from the 104 light chain: Ser 28 to VP0 residue Glu 285, Asn 93 to VP1 residue Asp 137, and Ser 30 to VP3 105 residue Gly 207, that have angles in the range of 138-180º and are closely spaced to stably interact 106 with exposed backbone nitrogen and oxygen atoms in the capsid proteins ( Figure 3B ). An 107 additional hydrogen bond may form between the Fab light chain residue Ser 67 and VP3 residue 108
Gln 209. However, the density in this area of the map was weak and because of this it was not 109 possible to assess whether suitable geometric conditions were met for the interaction to occur other 110 than the fact that the residue pair was in close proximity. One salt bridge between heavy chain 111 amino acid Glu 105 and VP3 residue His 206 was inferred by the fact that centroids of the 112 oppositely charged functional groups of the residues were within a 4 Å cutoff; and the Glu carbonyl 113 oxygen atom was within 4 Å distance from the nitrogen atom of the His side chain ( Figure 3B ). 114
This His 206 is centrally located in the footprint for the antibody and it was recently reported to be 115 critical for binding and neutralization based on experimental selection of an antibody AT12-015 116 resistant HPeV3 variant (VP3 His 206 to Tyr) (27). 117 118
Human monoclonal antibody AT12-015 prevents HPeV3 entry into cells 119
To probe HPeV3 A308/99-specific neutralization, we assayed whether binding of virions to human 120 intestinal HT-29 cells was blocked by the presence of human monoclonal antibody AT12-015 121 ( Figure 4A ). For antibody-mediated blocking, we pre-incubated equivalent amounts of virus with 122 antibody at 1:10, 1:100, 1:1000, and 1:10000 dilutions for 1 hour at 37º C and then added the 123 6 complexes to cells. Cellular attachment proceeded under ice-cold conditions for 1 hour and 124 afterwards unbound virions were removed with a series of gentle PBS wash steps. Cold binding 125 ensures that HPeV3 remains at the surface of cells and is not internalized. When preformed 126 antibody-decorated virions were added, either from mixing HPeV3 with stock or 1:10 dilution of 127 antibody, no fluorescence signal was observed on the surface of HT29 cells similar to the mock 128 infection (no virus) and antibody controls ( Figure 4B -stock, 1:10, mock, antibody no virus). 129
Small-sized clusters of virions were infrequently observed at excess levels of antibody ( Figure 4B -130 stock, 1:10). In contrast, staining was clearly visible on the surface of cells incubated with HPeV3 131 alone, as well as with higher dilutions of antibody, and fluorescence intensity was weaker at 1:100 132 dilution albeit with a high standard deviation ( Figure 4B -1:10000, 1:1000, and 1:100). Virus mixed 133 with 1:100 of antibody showed neutralizing activity without any apparent clumping ( Figure 4B -134 1:100). Taken together, these results indicate that AT12-015 neutralizes HPeV3 infection 135 extracellularly rather than by a post-attachment mechanism. 136
RNA inside the HPeV3 capsid 137
The HPeV3 virion contains ~7.4 kb of mostly unstructured single-stranded RNA genome. In the 138 assembled particle, roughly 25% of the RNA adopts a defined conformation near the inner capsid 139 surface, lining symmetry-related sites directly beneath the icosahedral five-fold vertices (19). For 140 parechoviruses, detailed structural analysis of genome-capsid interactions has only been carried out 141 for HPeV1 (21). Here we performed a similar analysis for HPeV3. The inside of our 2.8 Å HPeV3 142 map shows stretches of RNA in the same region as defined for HPeV1. The RNA has a defined 143 tertiary structure, forming a single-stranded loop with a significant portion involved in a rigid base-144 stacking motif that is capped by an aromatic side chain residue Trp 24 of VP3 with a small 145 conjugated π system ( Figure 5A and B). In this way, the tryptophan has stabilized its π orbitals to a 146 resonance level with the aromatic orbitals of adjacent RNA bases to enable efficient packaging and 147 formation of stable virions. EM density for the planar stacking profile is well-resolved, on the order 148 of 25 Å in length, before reaching a helix-coil transition ( Figure 5B ). Coordinates for the six RNA 149 7 nucleotides from previous structural work on the HPeV1 virion are in good agreement with our 150 modeled stacking motif. We fitted eight bases of RNA beneath the capsid, which included a portion 151 of the packaging sequence described recently for HPeV1 (22). The final sequence docked was U 0 -152
Using the RNA motif we searched the HPeV3 A308/99 genome (Genbank 153 code AB084913) and identified 33 sequences that contained G 1 -purine 2 -U 3 -purine 4 -U 5 , 13 of which 154 include the full motif X 0 -G 1 -purine 2 -U 3 -purine 4 -U 5 -X 6 -X 7 -U 8 . 155
In addition to modeling the Trp 24-RNA contact in the cryo-EM structure, two other residues from 156 the same VP3 strand, Lys 21 and Tyr 22, were found to interact with a neighboring RNA loop. 157
These residues, along with Trp 24, in the context of the assembled pentamer, appear to be key for 158 stabilizing the stacked RNA below the capsid vertex ( Figure 5C ). In fact, mutation of two of the 159 amino acids, either Tyr 22 or Trp 24 to alanine, in HPeV1 is lethal confirming their essential role in 160 virion assembly (22). Other capsid residues that further support the RNA loop under the vertex 161 were identified in VP1, as well as VP3. Specifically, VP1 residues Arg 202, Cys203, and Asn 205, 162 and VP3 residues Ala 18, Ser 19, Thr20, Leu 44, Thr 47, Arg 58, Phe 60, Tyr 61, and Arg 71, many 163 of which are aromatic or positively charged, form important RNA base and backbone contacts, as 164 well as complement the negative charge of the RNA ( Figure 5D ). In HPeV1, mutations of VP1 165 residues Arg 202 and Cys 203 to Ala as well as VP3 residues Thr 44, Arg 55, and Arg 68 to Ala 166 (VP3 residues Thr47, Arg 58, and Arg 71 in our structure) were shown to be lethal, indicating that 167 these residues are important for RNA packaging and virion assembly (22). 168
169
Discussion 170
Exact knowledge of the structural, antigenic, and immunogenic features of HPeV3 is essential for 171 understanding host-pathogen interaction, viral pathogenesis mechanisms, and for finding potential 172 cures for infection and disease, which is pressing as HPeV3 outbreaks are widespread and may 173 cause severe sepsis-like syndrome in neonates. Recently, we determined a structure of HPeV3 in 174 complex with Fab fragments from a human monoclonal antibody AT12-015 by cryo-EM (19). 175 8 However, the strain of virus used in that study, HPeV3 isolate 152037, was not neutralized by 176 addition of AT12-015. Furthermore the resolution of the reconstruction was only at 15 Å, which 177 prevented atomic characterization of the epitope on the surface of the viral capsid. Here we report a 178 2.8 Å-resolution cryo-EM structure of an AT12-015 Fab-decorated HPeV3 virion, isolate A308/99 179 that is neutralized by the monoclonal antibody from infecting human intestinal HT29 cells. In the 180 high-resolution structure, the antigen-antibody interface was well-defined and modeling of viral 181 coat proteins and Fab molecules into density revealed an extended conformational epitope across 182 the interface of adjacent asymmetric units, involving residues from different parts of neighboring 183 VP0, VP1, and VP3 chains spatially juxtaposed by the structure of the capsid. When bound, 184 monoclonal AT12-015 prevented virus attachment to target HT29 cells except for at high dilutions 185
of antibody, indicating that neutralization occurs extracellularly and not by a post-attachment 186 mechanism. In this way, we were able to identify the epitope of AT12-015 and determine how the 187 antibody works against HPeV3 A308/99. In addition, the 2.8 Å map provided the most complete 188 picture yet of ordered RNA on the inside of a human parechovirus. 189 Antibody AT12-015 was first isolated from the immune repertoire of a person with HPeV3 infection 190 using the AIMSelect method and it broadly recognizes strains of HPeV3 but only neutralizes the 191 prototype A308/99 virus that we used in the study (19, 27, 28) . At high resolution we could clearly 192 specify the conserved conformational epitope shared among HPeV3 strains, including solvent- Thus we can confirm a key role for VP3 His 206 in driving complex formation. 203
Because antibodies often prevent virus attachment and entry into target cells, we tested whether 204 AT12-015 blocks HPeV3 A308/99 binding to human intestinal HT29 cells. We found that mixing 205 antibody with virions under saturating conditions efficiently inhibits viral adhesion to cells and this 206 effect is only reversed at high dilutions of the antibody. In the presence of high amounts of AT12-207 015 small clumps of virus particles were infrequently observed, indicating that antibody-mediated 208 aggregation plays a minor role in exacerbating adherence. Neutralization occurs thus presumably by 209 either directly or indirectly preventing receptor engagement. Such specific targeting rather than 210 generalized clumping is supported by the fact that of all HPeV3 strains bound by AT12-015, only 211 isolate A308/99 is neutralized (27). To date, little is known about HPeV3 receptor and co-receptor 212 dependencies as it lacks the RGD motif and hence probably utilizes an uptake mechanism that 213 differs from other parechovirus types. This could account for type-specific neutralization, and in 214 general usage of a different receptor by HPeV3 likely influences tropism and thus the unique 215 disease severity in the human population. 216
It has become increasingly appreciated in recent years that for single-stranded RNA viruses, the life 217 cycle is in part regulated by the secondary and tertiary structure of their genomes, hence the current 218 high priority to understand protein-(single-stranded) RNA recognition motifs and RNA sequence-219 specific folding as it occurs in assembled virions (22, 29-33). Such information may help with 220 efforts to inhibit viral propagation, as well as in nanotechnology applications aimed at harnessing 221 either virus or virus-like systems for efficient gene delivery (34). Based on our cryo-EM data, we 222 propose a mechanism for adding HPeV3 RNA to assembling shells that utilizes π electron 223 delocalization from VP3 side chain Trp 24 to assist with nucleotide binding. Here, at the 224 mechanistic level, RNA folding is stabilized by a capsid-locking step where Trp 24, accessible on 225 the inner surface of capsid protein VP3, forms a geometrically favorable short-range stacking 226 interaction with a purine, which is then further strengthened by long-range interactions as a result of 227 10 electronic resonance through further stacking of adjacent nucleotides. The 14 additional highly 228 conserved capsid residues: VP1 Arg 202, Cys 203 and Asn 205, VP3 Ala 18, Ser 19, Thr 20, Lys 21, 229
Tyr 22, Leu 44, Thr 47, Arg 58, Phe 60, Tyr 61, and Arg 71 help to position the ordered RNA loop 230 against the inside of the capsid. From an evolutionary perspective, this means that over time the 231 inner surface of the virus has been fine-tuned to orchestrate the interaction between VP3 Trp 24 and 232 discrete sequences of genomic RNA, and that likewise the spacing of recognition motifs on the 233 HPeV3 genome has been thermodynamically optimized so as to minimize the free energy of capsid 234 assembly. 235
Methods 236

Virus sample preparation 237
Human colon adenocarcinoma (HT29) cells were propagated in McCoy's 5A medium supplemented 238 with 1X non-essential amino acids, 1X antibiotic-antimycotic, and 10% fetal bovine serum with the 239 culture condition of 37ºC and 5% CO 2 . Cells were grown to ~90% confluency before inoculating 240 with human parechovirus 3 (HPeV3) isolate A308/99 at a multiplicity of infection of 0.1. HPeV3 241 A308/99 was grown in fresh medium as described above except that the medium was slightly 242 modified to contain 1 mM MgCl 2 , 20 mM HEPES pH 7.4 and no FBS. Inoculated cells were 243 incubated at 37ºC for 3 days. Cells and medium were harvested. At this point concentration of 244 HEPES was increased to 40 mM final concentration. The cells were opened by three freeze-thaw 245 cycles and virus-containing medium was clarified by low-speed centrifugation. Afterwards the 246 supernatant was carefully removed and concentrated via ultrafiltration using Centricon units with a 247 cut-off at 100 kDa in weight. For purification, we applied a CsCl density gradient (top -1.2502 g 248 cm -3 , bottom -1.481 g cm -3 ) combined with ultracentrifugation (32,000 rpm, 4ºC) for 18 hours in a 249
Beckman type SW41 Ti rotor. The virus band was collected and the buffer exchanged into 1X TNM 250 buffer: 10 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1 mM MgCl 2 . Ultracentrifugation and buffer 251 exchange were repeated. Concentration was estimated by Coomassie-blue-stained SDS-PAGE gel, 252 11 where different concentrations of bovine serum albumin solution were used as standards. Infectivity 253 was measured using a TCID50 endpoint dilution assay. 254
Generation of antigen-binding Fab fragment 255
HPeV3 A308/99-specific monoclonal antibody (AT12-015) was obtained from AIMM Therapeutics 256 (the Netherlands). AT12-015 antibody was digested to produce antigen-binding Fab fragments using 257 the Pierce Fab micro preparation kit (Pierce). The Fab concentration was assessed by Coomassie-258 blue-stained SDS-PAGE gel, where different concentrations of bovine serum albumin solution were 259 used as standards. For complex formation, 30 µL of 0.1 µg/µL virus and 9 µL of 0.1 µg/µL antibody 260 were mixed (1:60 molar ratio) and incubated for 1 hour at 37ºC. 261
Cryo-EM data acquisition 262
Sample volumes of 3 µL of purified HPeV3 A308/99-Fab complex were applied to glow-discharged 263 ultrathin carbon-coated lacey 400-mesh copper grids (Ted Pella product #01824) and vitrified using 264 a custom-made manual plunger. Cryo-grids were visualized with a FEI Titan Krios electron 265 microscope operating at 300 kV accelerating voltage, at a nominal magnification of 75,000× using a 266 FEI Falcon II direct electron detector, corresponding to a pixel size of 1.06 Å on the specimen level. 267
In total, 6,541 images with defocus values in the range of -0.5 to -2.5 µm were recorded in movie 268 mode with 1 second of total acquisition time. Each movie contained 18 frames with an accumulated 269 dose of about 48 electrons per Å 2 . 270
Image processing and 3D reconstruction 271
Dose-fractionated image stacks containing frames from 2 to 17 were subjected to beam-induced 272 motion correction using MotionCor2 (35). Estimation of contrast transfer function parameters for 273 each micrograph was done using Gctf (36). Particle selection, 2D classification, and 3D 274 classification were performed on an unbinned dataset (1.06 Å/pix, 480 pixel box size) using 275 RELION 2.0 (26). In total, 217,212 particle projections were selected. After reference-free 2D 276 classification in RELION in the best classes containing 179,457 particle projections were used for 277 further processing. A ~ 10 Å reference map generated in AUTO3DEM from a modest-sized dataset 12 of 2050 particle images collected on a FEI Tecnai TF20 cryo-electron microscope filtered to 60 Å 279 was used for initial maximum-likelihood-based 3D classification (37). Three classes accounting for 280 74,927 particles were selected for 3D refinement and reconstruction. During post-processing step in 281 RELION the map was masked with a soft mask and sharpened using a B-factor -70 Å 2 . The final 282 refinement resulted in a 2.8 Å map based on the gold-standard Fourier shell correlation 0.143 283 criterion. Local resolution was determined using ResMap with the unsharpened map as an input 284 (38). 285
Atomic model building and refinement 286
An initial atomic model for the HPeV3 A308/99-Fab complex was generated using I-TASSER and 287 SWISS-MODEL based on the crystal structure of the HPeV1 virion (PDB ID: 4Z92) and Fab 288 fragments of human monoclonal antibody AM28 (PDB ID: 4UDF) (21, 39-41). Docking of atomic 289 coordinates was done manually using UCSF Chimera and the fit was further optimized using the 290 'Fit in Map' command (42). Inspection and further refinement was done using Coot 0.8.8 and this 291 served as input for molecular dynamics flexible fitting (MDFF) (43). The MDFF program was used 292 together with NAMD and VMD to further enhance the fit of models into cryo-EM density (44-46). 293 A scale factor of 1 was employed to weigh the contribution of the cryo-EM map to the overall 294 potential function used in MDFF. Simulations included 20,000 steps of minimization and 100,000 295 steps of molecular dynamics under implicit solvent conditions with secondary structure restraints in 296 place. To achieve the best fit of the model to the cryo-EM density three iterations between Coot and 297 MDFF were performed with the last step being relaxation of the structure by an energy 298 minimization step using MDFF. For hydrogen bond detection at the virus-antibody interface we 299 examined structure in UCSF Chimera using a strict distance cutoff of 3.6 Å and for geometrical 300 constrains we only included hydrogen bonds within the range of 138 -180º (47, 48). RNA-protein 301 interface was analyzed in UCSF Chimera using the same (3.6 Å) distance cutoff. 302
Binding assay 303 13 HT29 cells were seeded on 96-well plates at a density of 40000 cells per well in the same culture 304 conditions as during virus sample preparation. Antibody AT12-015 was incubated as stock (0.5 305 mg/ml) or as a dilution (1:10, 1:100, 1:1000, 1:10000) with 1x CsCl-gradient purified HPeV3. 306
Specifically, 2 µL of antibody was mixed with 2 µL of virus (8 * 10^5 pfu/ml) for 1 hour at 37 °C. 307
The incubation took place in McCoy's 5A medium supplemented with 1X GlutaMAX, 1X non-308 essential amino acids, 1X antibiotic-antimycotic, 20 mM HEPES, and 30 mM MgCl 2 . Plates 309 containing cells and tubes containing antibody-virus complexes were placed on ice and allowed to 310 cool. Growth medium of the cells was exchanged to cold-binding medium. Antibody-virus 311 complexes, as well as either viruses or antibodies alone were then added to cells and incubated for 1 312 hour at ice-cold temperature. After incubation, cells were washed 3 times with 0.5 % BSA-PBS. For 313 wells containing antibody-decorated virus, the primary staining step was skipped. Otherwise, AT12-314 015 was used as a primary antibody (diluted in 0.5% BSA-PBS) for unlabeled virus or in wells 315 designated to serve as an antibody control. After three additional washing steps, secondary antibody 316 was added for 1 hour. A further series of washes was carried out and Hoechst (1 ug/ml) was added 317 for visualization of cell nuclei. Wells were then washed a last time and plates were sealed. 318
High content imaging and analyses 319
All experiments were performed in 96-well plates (Perkin Elmer) and images were acquired using 320 the automated fluorescence microscope CellInsight from Thermo Scientific. Image analysis was 321 completed using CellProfiler (http://cellprofiler.org)). 322
Accession numbers 323
The final density map has been deposited to Electron Microscopy Databank (EMDB) with 324 accession code EMD-0069 (https://www.ebi.ac.uk/ebisearch/search.ebi?db=allebi&query=emd-325 0069&requestFrom=searchBox). The atomic model has been deposited to Protein Databank (PDB) 326 with accession code 6GV4 (http://www.ebi.ac.uk/pdbe/entry/pdb/6gv4). 
